SRC-Mediated Regulation of the PI3K Pathway in Advanced Papillary and Anaplastic Thyroid Cancer

Oncogenesis - United States
doi 10.1038/s41389-017-0015-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anaplastic Thyroid Cancer Evolved From Papillary Carcinoma

Archives of Otolaryngology–Head & Neck Surgery
2003English

O-GlcNAcylation Enhances the Invasion of Thyroid Anaplastic Cancer Cells Partially by PI3K/Akt1 Pathway

OncoTargets and Therapy
OncologyPharmacology
2015English

SRY‑related HMG Box‑2 Role in Anaplastic Thyroid Cancer Aggressiveness Is Related to the Fibronectin 1 and PI3K/AKT Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

SRC Inhibitors in Suppression of Papillary Thyroid Carcinoma Growth

Head and Neck
Otorhinolaryngology
2013English

MicroRNA‑766 Inhibits Papillary Thyroid Cancer Progression by Directly Targeting Insulin Receptor Substrate 2 and Regulating the PI3K/Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma

Asian Pacific Journal of Cancer Prevention
2019English

Metastatic Papillary Thyroid Carcinoma With Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma

Case Reports in Pathology
2016English

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

Unusual Manifestation of Anaplastic Thyroid Cancer

Acta medica (Hradec Kralove)
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy